President Donald Trump is poised to nominate Stephen Hahn, a top official at MD Anderson Cancer Center in Houston, to be the next commissioner of the Food and Drug Administration, according to people familiar with the situation. The announcement could come as soon as Thursday.
If confirmed, Hahn would head an agency that regulates a broad swath of the U.S. economy, including brand-name and generic drugs, medical devices, much of the nation’s food supply and tobacco products. It is currently embroiled in a high-profile controversy over youth vaping and the president’s decision to ban most flavored e-cigarettes. Along with the Centers for Disease Control and Prevention, the FDA is investigating an outbreak of vaping-related lung illnesses and is developing the previously announced e-cigarette ban to try to reduce youth vaping.